Herborium Group, Inc. provided revenue guidance for the year 2013. Based on the results of the third quarter, and estimated performance in the fourth quarter 2012, as well as rapid growth of sales and popularity of Kamasutra(TM) spirit containing the company's proprietary herbal formulation, the company expects estimated revenues in 2013 to reach 7 figures.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 1.09M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- HBRM Stock
- News Herborium Group, Inc.
- Herborium Group, Inc. Provides Revenue Guidance for the Year 2013